Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus

Journal of Pediatric Surgery

Volumn 34, Issue 5, 1999, Pages 766-773

  Yang, Edmund Y ^a   Kim, Heung Bae ^a   Shaaban, Aimen F ^a   Milner, Ross ^a   Adzick, N Scott ^a   Flake, Alan W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Adenovirus; Fetus; Gene therapy; Liver; Mouse; Muscle; galactosidase

Indexed keywords

BETA GALACTOSIDASE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; BONE MARROW; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FETUS; GENE EXPRESSION; GENE THERAPY; GENOME; LIVER; LUNG; MALE; MARKER GENE; MOUSE; MUSCLE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; SPINAL GANGLION; STROMA; TRANSGENE; VIRUS RECOMBINANT;

EID: 13044280785     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(99)90371-8     Document Type: Conference Paper

References (27)

1. Yang Y, Nunes F, Berencsi K, et al: Cellular immunity to viral antigens limits E-1 deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91:4407-4411, 1994
2. Yang Y, Jooss KU, Su Q, et al: Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 3:137-144, 1996
3. Solomon J: Foetal and neonatal immunology, in Neuberger A, Tatum E, (eds): Frontiers of Biology, Vol 20. New York, NY, American Elsevier, 1971, pp 234-306
4. Nogee LM: Surfactant protein-B deficiency. Chest 111:129S-135S, 1997
5. Morsy MA, Caskey CT: Ornithine transcarbamylase deficiency: A model for gene therapy. Adv Exp Med Biol 368:145-154, 1994
6. L'Argilliere C, Houssin D, Gottrand F, et al: Liver transplantation for ornithine transcarbamylase deficiency in a girl. J Pediatr 115:415-417, 1989
7. Ploos van Amstel JK, Bergman AJ, van Beurden EA, et al: Hereditary tyrosinemia type 1: Novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship. Hum Genet 97:51-59, 1996
8. Chen Y-T, Burchell A: Glycogen storage diseases, in Scriver C, Beaudet A, Sly W, et al (eds): Metabolic and Molecular Basis of Inherited Disease, (ed 7). New York, NY, McGraw-Hill, 1995, pp 935-965
9. Hayashi SI, Morishita R, Aoki M, et al: In vivo transfer of gene and oligodeoxynucleotides into skin of fetal rats by incubation in amniotic fluid. Gene Ther 3:878-885, 1996
10. Douar AM, Adebakin S, Themis M, et al: Foetal gene delivery in mice by intraamniotic administration of retroviral producer cells and adenovirus. Gene Ther 4:883-890, 1997
11. Holzinger A, Trapnell BC, Weaver TE, et al: Intraamniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 38:844-850, 1995
12. McCray PB Jr, Armstrong K, Zabner J, et al: Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest 95:2620-2632, 1995
13. Vincent MC, Trapnell BC, Baughman RP, et al: Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther 6:1019-1028, 1995
14. Pitt BR, Schwarz MA, Pilewski JM, et al: Retrovirus-mediated gene transfer in lungs of living fetal sheep. Gene Ther 2:344-350, 1995
15. Sylvester KG, Yang EY, Cass DL, et al: Fetoscopic gene therapy for congenital lung disease. J Pediatr Surg 32:964-969, 1997
16. Yang EY, Cass DL, Sylvester KL, et al: Fetal gene therapy: Efficacy, toxicity, and immunologic effects of early gestation recombinant adenovirus. J Pediatr Surg (in press)
17. Tripathy SK, Goldwasser E, Lu MM, et al: Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc Natl Acad Sci U S A 91:11557-11561, 1994
18. Evans MI, Quintero RA, King M, et al: Endoscopically assisted, ultrasound-guided fetal muscle biopsy. Fetal Diagn Ther 10:167-172, 1995
19. Graham FL, Smiley J, Russell WC, et al: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74, 1977
20. Graham FL, Van der Erb AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:546-567, 1973
21. Tripathy SK, Black HB, Goldwasser E, et al: Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2:545-550, 1996
22. Acsadi G, Jani A, Massie B, et al: A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet 3:579-584, 1994
23. Whitley R: Herpes simplex viruses, in Fields B, Knipe P, (eds): Fields Virology (ed 2). Philadelphia, PA, Lippincott-Raven, 1990, pp 1843-1887
24. Yang Y, Haecker SE, Su Q, et al: Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 5:1703-1712, 1996
25. Michou A, Santoro L, Christ M, et al: Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther 4:473-482, 1997
26. Gao GP, Yang Y, Wilson JM: Biology of adenovirus vectors with El and E4 deletions for liver-directed gene therapy. J Virol 70:8934-8943, 1996
27. Shenk T: Adenoviridae: The viruses and their replication, in Fields B, Knipe P, Howley P, (eds): Fields Virology (ed 3). Philadelphia, PA, Lippincott-Raven, 1996, pp 2111-2148